Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Timothy Wierson

Surgery Bowling Green, KY Medical Doctor

NPI 1295731602 CMS profile 12886

484 Golden Autumn Way Ste 201, Bowling Green, KY 42103

Open in the dashboard

General payments

$51,372

129 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Timothy Wierson of Bowling Green, KY is reported in the CMS Open Payments database as having received $51,372 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,551 22
2024 General $5,826 14
2023 General $1,658 18
2022 General $705 14
2021 General $1,156 20
2020 General $21,585 28
2019 General $5,891 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Wierson
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Timothy Wierson were reported at $14,551. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Timothy Wierson Surgery median Middle half National median
2019 $5,891 $253 $82–$1,521 $163
2020 $21,585 $131 $40–$706 $114
2021 $1,156 $168 $50–$904 $132
2022 $705 $224 $76–$1,218 $149
2023 $1,658 $253 $82–$1,255 $160
2024 $5,826 $279 $90–$1,381 $164
2025 $14,551 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $47,806 56 payments
  2. Boston Scientific Corporation $827 18 payments
  3. Medtronic, Inc. $728 10 payments
  4. AngioDynamics, Inc. $510 4 payments
  5. TELA Bio, Inc. $385 8 payments
  6. Medtronic Vascular, Inc. $207 4 payments
  7. W. L. Gore & Associates, Inc. $183 3 payments
  8. Stryker Corporation $151 4 payments
  9. Penumbra, Inc. $143 2 payments
  10. Endologix, Inc. $86 2 payments
  11. Other $345 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $42,089 13 payments
  2. Food and Beverage $6,503 102 payments
  3. Travel and Lodging $2,766 13 payments
  4. Gift $15 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $47,806 56 payments
  2. ENDURANT IIS $429 5 payments
  3. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $318 7 payments
  4. Endurant Aortic Stent Grafts $259 4 payments
  5. ELUVIA Eluvia_Pi $233 5 payments
  6. ELUVIA Stents $229 5 payments
  7. Solero $201 2 payments
  8. JETSTREAM SC $170 2 payments
  9. Endurant Aortic Stent Grafts $155 3 payments
  10. ELUVIA Pain Management $111 3 payments
  11. Other $1,274 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

176

Median for General Surgery: 59

Drug cost

$1,246

Median for General Surgery: $393

Branded share of claims

70.5%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates Brand 11 $538
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 113 $484
Oxycodone Hcl Generic 18 $89
Neomycin Sulfate Generic 17 $85
Metronidazole Generic 17 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 107 billing codes

Paid by Medicare

$127,798

Medicare's payments for the services billed

Medicare patients

325

Average age 73

Services billed

774

168 women, 157 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 35%
Diabetes 34%
Depression 32%
COPD 29%
Heart failure 27%
Chronic kidney disease 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record